Ikarian Capital »

Neumora Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Neumora Therapeutics (NMRA) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Neumora Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Neumora Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neumora Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $13M 1.3M 10.60
2024-09-30 $11M 800k 13.21

More positions owned by Ikarian Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Tyson Foods Cl A Put Option (TSN)
Tarsus Pharmaceuticals (TARS)
Crinetics Pharmaceuticals In (CRNX)
Bridgebio Pharma Call Option (BBIO)
Scholar Rock Hldg Corp Call Option (SRRK)
Amgen Call Option (AMGN)
Insmed Com Par $.01 Call Option (INSM)
Blueprint Medicines (BPMC)
Avidity Biosciences Ord Put Option (RNA)
Sarepta Therapeutics Call Option (SRPT)
Forte Biosciences Com New (FBRX)
Pilgrim's Pride Corporation Put Option (PPC)
Neumora Therapeutics Put Option (NMRA)
Miragen Therapeutics Call Option (VRDN)

View all positions for Ikarian Capital

Top funds holding Neumora Therapeutics

FMR
BlackRock
Softbank Group Corp
T. Rowe Price Investment Management
Vanguard Group
MIC Capital Management UK
Capital Research and Management Company - Division 3
Wellcome Trust Limited, as Trustee of the Wellcome Trust
Siren
ICONIQ Capital
Caption Management
EcoR1 Capital
State Street Corporation
Geode Capital Management
Johnson & Johnson

View all funds holding Neumora Therapeutics